GENPACT INDIA PRIVATE LIMITED
Location
Haryana
Founded
2005-02-10
Website
Risk Signals
421 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Programming Services, Computer Related Services, Not Elsewhere Classified, Business Services, Not Elsewhere Classified, Commercial Economic, Sociological, and Educational Research, Management Consulting Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about GENPACT INDIA PRIVATE LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-17 (borsvarlden.com)
C Worldwide Stable Equities decreased 5.9 percent in March - Novo Nordisk, Genpact and Vonovia contributed negatively
Foundation C Worldwide Stable equities 1C decreased 5.9 percent in March, which was worse than the Fund's comparison index which decreased 5.5 percent. Since the turn of the year, the fund has decreased 1.3 percent and is thus better than the index which has decreased 3.5 percent. This is stated in a monthly report from the Fund's manager Jakob Greisen.
Read more2025-01-30 (simplywall.st)
Is Genpact Limited's (NYSE:G) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Simply Wall St News
Genpact's (NYSE:G) stock is up by a considerable 25% over the past three months. Given that the market rewards strong...
Read more2025-01-14 (marketbeat.com)
Genpact Limited (NYSE:G) SVP Sells $513,960.00 in Stock
Genpact Limited (NYSE:G - Get Free Report) SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Read more2024-12-19 (marketscreener.com)
Genpact insider sold $606,560 worth of shares, according to a recent SEC filing -
-- Balkrishan Kalra, Director, President and CEO, sold 13,600 shares of Genpact stock for $606,560 on December 13, 2024. Following the filing of Form 4 with the SEC, Kalra has control…
Read more2024-12-09 (marketbeat.com)
Verition Fund Management LLC Has $1.03 Million Stock Holdings in Genpact Limited (NYSE:G)
Verition Fund Management LLC raised its position in Genpact Limited (NYSE:G - Free Report) by 139.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,268 shares of the business services provider's stock after purchasing
Read more
2024-11-18 (marketbeat.com)
Genpact Limited (NYSE:G) Receives Consensus Recommendation of "Hold" from Brokerages
Genpact Limited (NYSE:G - Get Free Report) has been assigned an average recommendation of "Hold" from the nine research firms that are covering the stock, Marketbeat reports. Eight investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The a
Read more
2024-11-05 (marketbeat.com)
New York State Common Retirement Fund Trims Stock Holdings in Genpact Limited (NYSE:G)
New York State Common Retirement Fund reduced its stake in Genpact Limited (NYSE:G - Free Report) by 14.3% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 564,689 shares of the business services provider's st
Read more
(investors.com)
Genpact Shows Improved Relative Price Performance; Still Shy Of Benchmark
Genpact shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Read more
(investing.com)
TD Cowen maintains Hold on Genpact stock amid CEO-driven changes By
TD Cowen maintains Hold on Genpact stock amid CEO-driven changes
Read more